Disordered N-terminal residues affect the folding thermodynamics and kinetics of maltose binding protein  by Ganesh, C. et al.
FEBS 22278 FEBS Letters 454 (1999) 307 311 
Disordered N-terminal residues affect the folding thermodynamics and 
kinetics of maltose binding protein 
C. Ganesh a, Antara Banerjee a, Aseema Shah a, Raghavan Varadarajan a,b,* 
aMolecular Biophysics Unit, Indian Institute qf Science, Bangalore 560 012, India 
bChemical Biology Unit, Jawaharlal Nehru Center jor Advanced Scient(fic Research, Jakkur, P.O. Bangalore 56(1 004, India 
Received 16 March 1999; received in revised form 17 May 1999 
Abstract Maltose binding protein (MBP) exhibits a slow phase 
of folding at pH 7.4, 298 K. The kinetics of this phase has been 
characterized as a function of denaturant concentration and 
temperature. Denaturant double-jump experiments and the 
activation energy for folding indicate that the slow phase involves 
processes other than proline isomerization. Although the first five 
N-terminal residues are disordered in the MBP crystal structure, 
mutations in this region slow down folding and destabilize the 
native structure. This is the first report showing that disordered 
N-terminal residues can affect folding kinetics and stability. 
© 1999 Federation of European Biochemical Societies. 
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1. Introduction 
Maltose binding protein (MBP) is a large, two domain pro- 
tein of 370 amino acid residues, present in the periplasm of 
Escherichia coli. The folding thermodynamics of MBP has 
been extensively characterized [1,2]. The kinetics of folding 
has also been characterized using manual  mixing [3]. MBP 
serves as a good model system to study folding of large pro- 
teins but its folding is complex, involving several phases. The 
slow phase observed uring the folding of several proteins has 
been attr ibuted to isomerization about the X-Pro peptide 
bond in the polypeptide backbone. This typically occurs 
with a rate constant of about 10 -3 s -1 [4]. There are 21 pro- 
line residues in MBP, all in the trans-conformation i the 
folded structure [5]. The slow phase of MBP folding is further 
retarded by the E. coli chaperone SecB, which is involved in 
the translocation of MBP across the bacterial inner membrane 
in vivo [6]. 
In the present study, the slow phase of MBP folding has 
been investigated by fluorescence spectroscopy under different 
folding conditions to assess the involvement of proline resi- 
dues in the folding pathway. In order to obtain larger 
amounts of protein than those obtained through periplasmic 
expression, MBP was expressed in the cytoplasm using a de- 
rivative of the plasmid pMalc> The cytoplasmic (cmMBP) 
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and periplasmic (pmMBP) proteins differ only at two N ter- 
minal positions which are disordered in the crystal structure 
of pmMBP.  Surprisingly, cmMBP is destabilized and folds 
more slowly than pmMBP.  This is the first report showing 
that disordered N-terminal residues can affect folding kinetics 
and stability. 
2. Materials and methods 
2.1. Materials' 
Ultra-pure guanidinium hydrochloride, HEPES and urea were ob- 
tained from USB and ultra-pure Tris was from Gibco BRL. ANS, 
IPTG, maltose and PMSF were from Sigma. Either deionized, double 
distilled water or milliQ water was used for preparing all solutions. A
stock solution of 0.1 M ANS was prepared in water and filtered just 
prior to use. ANS concentration was estimated using e3s0 = 5000 M -t 
cm -1 [7]. Buffers CGH10 and CGH1 were prepared as described ear- 
lier [2]. Pure acetonitrile was distilled and all solvents for HPLC were 
filtered and degassed just prior to use. All reverse-phase HPLC runs 
were carried out using a VYDAC CI8 semi-preparative column. Pure 
cyanogen bromide (CNBr) was obtained locally and stored under 
cold, dry conditions. All other eagents were of analytical grade purity 
and obtained locally. 
2.2. Cloning, protein purification and chemical cleavage 
Mature MBP was directly purified from the E. eoli periplasm as 
described earlier [2]. Mature MBP, lacking the leader sequence, was 
also separately cloned and overexpressed in E. coli, using the fusion 
protein vector pMALc2 from New England Biolabs, Massachusetts, 
USA. pMALc2 was double digested with BglIl and HindIII and the 
resultant large fragment purified. Vector pBSKS+malE was con- 
structed by ligating the 1738 bp EcoRI-HindIII fragment of 
M13malE containing the wild-type MBP coding sequence into 
pBSIIKS +. pBSKS+malE was double digested with BglII and HindIII 
and the small fragment obtained at this step was ligated to the large 
fragment from pMALc> The resultant vector was pMALcmMBP and 
it was used for cytoplasmic expression of mature MBP. In this con- 
struct, amino acids 1-144 are from pMALc2 and 145-370 are derived 
from M13malE. 
Overexpressed MBP was obtained in a highly soluble form from E. 
coli cytosol using the above vector, and is referred to as cytoplasmic 
mature MBP (cmMBP). This nomenclature is used to differentiate it 
from the authentic wild-type periplasmic mature protein (pmMBP). 
cmMBP was purified from E. coli DH5c~ cells harboring the plasmid 
pMALcmMBP, cmMBP was extracted using a procedure described 
for another cytosolic protein [8] and purified by the same procedures 
used for pmMBP purification [2]. Concentrated stocks of proteins 
were stored at -70°C. MBP was chemically cleaved at its m.ethionine 
residues by cyanogen bromide, as described [9]. Cyanogen bromide 
was used for analytical purposes only and not during any step of 
protein purification. Pure proteins and fragments were analyzed by 
SDS-PAGE, HPLC and MS. 
Abbreviations: MBP, maltose binding protein; CGH, equimolar cit- 
rate-glycine-HEPES; MS, mass spectrometry; ESI, electrospray ion- 
ization; TOF, time of flight; MALDI, matrix assisted laser desorption 
ionization; cm, cytoplasmic mature protein; pro, periplasmic mature 
protein; k, rate constant; f, folding; u, unfolding; AG, free energy 
change; Cm, denaturant concentration at which half the molecules are 
unfolded; E~, activation barrier; LA, lactalbumin 
2.3. Spectroscopic measurements and data analyses 
All fluorescence measurements were made in a JASCO FP777 spec- 
trofluorimeter fitted with a thermostatted cuvette holder. All temper- 
atures reported here are that of the sample and have an accuracy of 
+ 0.1°C. Three to six individual measurements were made for all ex- 
periments and the mean and standard eviation are reported. Excita- 
tion was at 280 nm and the emission was measured either at 341 nm 
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(for folding kinetics) or scanned (for equilibrium experiments) at 100 
nm min -~ with a time constant of 4 s. ANS binding experiments were 
performed using an excitation of 380 nm and emission scanned from 
425 to 575 nm. Excitation and emission slit widths were 1.5 and 5 nm 
respectively in all cases. Refolding kinetics experiments were per- 
formed as described in [6]. Urea denaturation studies were performed 
at pH 7.4 in the presence of 0.15 M potassium chloride and all sam- 
ples incubated until equilibria were established under the given set of 
conditions. For ANS binding experiments, 3 BM ANS was used. All 
protein concentration estimations, maltose binding titration and CD 
measurements were performed as described in [2]. 
Equilibrium unfolding was carried out as described previously [2]. 
The data were fitted to a two-state model by a non-linear least squares 
fitting procedure [10] to obtain AGD, the free energy change upon 
unfolding as a function of denaturant concentration. The linear ex- 
trapolation model [10] was used to obtain AG ° and the m value (the 
intercept and slope respectively of a plot of AGD VS. denaturant con- 
centration) for the protein. Cm (the denaturant concentration atwhich 
AGD is zero) is given by the ratio AG°/m. Refolding and unfolding 
kinetic traces were both fitted to a single exponential as 
F(t)=a[l exp(-k  t)]+b and F(t)=a exp( k t)+b respectively. The 
dead time due to manual mixing was 6-8 s. In all the manual mixing 
studies reported here, the refolding kinetics were well described by a 
single exponential. All non-linear least squares fitting routines were 
unconstrained fits. 
2.4. Analytical techniques 
SDS-PAGE runs were carried out as described in [2]. PAGE under 
native conditions was performed at 7-10°C inside a cold room, using 
a buffer o fpH 8.8. ESI-MS was performed on an HPl l00 MSD and 
MALDI measurements made using a TOF KOMPACT SEQ machine 
from Kratos. The error in reported mass measurements by ES1-MS is 
about 1 Da in 10 kDa. Automated N-terminal sequencing was per- 
formed for both the proteins for several rounds. 
3. Results 
The refolding of  both pro- and cmMBP is highly reversible, 
as judged from the final f luorescence yield and maltose bind- 
ing characterist ics o f  the refolded material  (data not shown).  
The individual rates and ampl i tudes for folding and unfolding 
under  different condit ions are shown in Table I. Examinat ion  
o f  the data indicates that the two proteins differ only in their 
refolding rates while their unfold ing rates are identical. The 
relative ampl i tudes of  the fast and slow phases in both  un- 
folding and refolding are identical in the two proteins. Both 
pm-  and cmMBP exhibit similar affinity for b inding maltose 
(data not  shown).  
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Fig. 1. A: Double-jump refolding experiment for pmMBP (4 M to 
0.2 M GdnHC1 jump). Shown are the changes in slow ( ) and fast 
phase (Q) amplitudes as a function of increasing unfolding pulse. 
Also shown (solid line) is the single exponential fit for the rise in 
slow phase amplitude. B: Arrhenius plot for pmMBP refolding in 
0.05 M GdnHC1. C: E~ values for the slow phase of pmMBP re- 
folding at different denaturant concentrations. Experimental condi- 
tions similar to that mentioned under A. 
Table 1 
Kinetic parameters for folding and unfolding of MBP at 298 K, pH 7.4 
[GdnHCI] (M) a (normalized) k (S - I  ) b (normalized) 
Unfolding 
1,50 pmMBP 0.700 ( + 0.005) 0.0038 (-+ 0.001) 0.300 ( ± 0.005) 
cmMBP 0.658 ( _+ 0.020) 0.0037 (+ 0.0001) 0.342 ( + 0.02) 
1.75 pmMBP 0.710 ( ± 0.003) . 0.0126 (± 0.002) 0.290 ( £ 0.003) 
cmMBP 0.681 ( ± 0.003) 0.0131 ( + 0.003) 0.319 ( + 0,003) 
1.85 pmMBP 0.714 ( ± 0.001 ) 0.0249 ( ± 0.005) 0.286 ( ± 0,001) 
cmMBP 0.685 ( ± 0.01) 0.0194 ( ± 0.006) 0.315 ( ± 0.01) 
2.00 pmMBP 0.722 ( ± 0.015) 0.0495 ( ± 0.001) 0.278 ( ± 0,015) 
cmMBP 0.677 ( ± 0.005) 0.0444 ( + 0.002) 0,323 ( ± 0.005) 
Folding 
0.1 pmMBP 0.382 ( ± 0.003) 0.0317 ( ± 0.003) 0.618 ( ± 0.003) 
cmMBP 0,385 ( + 0.010) 0.0235 ( ± 0,0013) 0.615 ( + 0.010) 
0.2 pmMBP 0.394 ( ± 0.004) 0.0265 ( ± 0.002) 0.606 ( $ 0,004) 
cmMBP 0.397 ( + 0.002) 0.0191 ( ± 0.0007) 0.603 ( _+ 0.002) 
0.3 cmMBP 0.416 ( ± 0.007) 0.0141 ( _+ 0.0004) 0.584 ( ± 0.007) 
0,4 pmMBP 0.423 ( _+ 0.008) 0.0174 ( _+ 0.001 ) 0.577 ( +_ 0.008) 
cmMBP 0.423 ( ± 0,011) 0.0119 ( ± 0.0006) 0.577 ( ± 0.011) 
0.5 pmMBP 0.433 ( _+ 0,008) 0.012 ( ± 0.0003) 0.567 ( ± 0.008) 
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The slow phase of pmMBP folding was further investigated 
by the double-jump technique [4]. In these experiments he 
protein was unfolded in 4 M GdnHC1 for varying amounts 
of time and then transferred to refolding conditions. The rel- 
ative amplitudes of both the fast and slow phases of refolding 
as a function of incubation time in 4 M GdnHC1 are shown in 
Fig. 1A. The build-up of the slow phase occurs with a rate of 
0.11 s 1 in 0.2 M GdnHC1 and this rate depends on the final 
GdnHC1 concentration i  the folding solution (data not 
shown). The activation energy (E~) for the slow phase was 
estimated by examining the temperature dependence of the 
refolding rate in the range 20 37°C and fitting the data to 
the Arrhenius equation k = A exp( - -Ea /RT)  (Fig. 1B). Refold- 
ing experiments showed that E~ is relatively independent of
denaturant concentration (Fig. 1C) and was estimated to be 
15_+ 1.6 kcal mol 1. 
The secondary CD of cmMBP is shown and compared to 
that of pmMBP in Fig. 2A. The secondary structural content 
of cmMBP appears to be very similar to that of pmMBP [2]. 
ANS binding to pm- and cmMBP were examined at both pH 
2.8 and pH 7.4 (data not shown); it was found that both the 
proteins bind ANS only at the lower pH and not at 7.4. It has 
been shown previously that pmMBP forms a molten globule 
below pH 3 [2] and cmMBP also forms a molten globule 
under these conditions. Taken together, these results suggest 
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Fig. 2. A: Secondary CD of cmMBP at pH 7.4 and 2.8 at 21°C ((2), 
VJ); continuous lines indicate CD of pmMBP under similar condi- 
tions. B: Urea denaturation; experimental data points for pm- (©), 
cmMBP (D) and (solid line) curves fitted for a two-state unfolding 
transition. 
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Fig. 3. ESI-MS of a 2:1 mixture of HPLC purified intact pro- and 
cmMBP. A: Actual charged states observed. B and C: Distribution 
of two distinct sets of charged states. D: Deconvoluted charge states 
yield only two unique masses, indicated in the figure. 
that under native conditions, there may not be large-scale 
overall rearrangements in cmMBP compared to pmMBP but 
we do not rule out minor localized changes. The stability of 
both proteins was examined by performing equilibrium un- 
folding studies in urea. The values at pH 7.3 and 25°C for 
AG °, m and Cm were 15.4 (+ 1.2) kcal mol 1, 4.9 (+0.4) kcal 
mol ] M 1 and 3.15 M for pmMBP and 11.9 (+0.9) kcal 
mol -I,  4 (+0.3) kcal tool ] M 1 and 2.96 M for cmMBP. 
Thus, cmMBP is destabilized at room temperature when com- 
pared to pmMBP. 
The molecular weights of both pm- and cmMBP were ac- 
curately determined by ESI-MS (Fig. 3). Both the proteins 
were cleaved by CNBr, the resultant fragments purified by 
HPLC and analyzed by both ESI-MS and MALDI-MS. The 
results are presented in Table 2. Automated protein sequenc- 
ing indicated the presence of the following sequence at the N- 
termini: pmMBP, KIEEGKLV and cmMBP, MKTEEGKL. 
These are consistent with the known DNA sequences of wild- 
type MBP and pMALc2 respectively. Native PAGE (data not 
shown) indicated that both pmMBP and cmMBP exhibit sim- 
ilar electrophoretic mobility under native conditions. All the 
available data suggest that pmMBP and cmMBP differ only at 
two amino acids in the amino terminus of the protein. The 
310 
Table 2 
ESI-MS analyses of pmMBP, cmMBP and CNBr digestion products 
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Protein Fragment Position Expected MW (Da) Observed MW (Da) 
pmMBP 
cmMBP 
Intact 1 370 40 707 40707 
1 1 148 16471 16471 
2 149 204 6 221 6221 
3 205 321 12474 12474 
4 225-321 10403 10403 
5 322 330 971 971 
6 331 336 651 651 
7 331 370 4390 4390 
8 337 370 3 739 3 743 
Intact 1 371 40826 40824 
1 2-149 16459 16464 
2 150 205 6221 6 221 
3 206 322 12474 12476 
4 226-322 10403 10404 
5 323 331 971 971 
6 332 337 651 651 
7 338 371 3739 3739 
first five N-terminal residues containing these two mutations 
are disordered in the crystal structure of pmMBP. Despite 
this, the mutations affect the refolding kinetics and stability 
of MBP. 
4. Discussion 
The rate constants and amplitudes for the refolding kinetics 
reported here show good agreement to those previously re- 
ported [3,6,11]. The slow phase of folding of pmMBP has 
been further investigated in this study. The value of Ea for 
the slow phase is 15+1.6 kcal mol -I. This is significantly 
different from that expected (20 kcal mol 1) for proline cis- 
lrans isomerization [4]. The observed rate for slow phase am- 
plitude build-up estimated from double-jump experiments was 
found to be about 100 times faster than that expected for the 
isomerization process. Thus, the slow phase of folding in this 
large protein must involve structural rearrangements other 
than proline isomerization. Since the N-terminal mutant, 
cmMBP, folds more slowly than pmMBP, residues close to 
the N-terminus are likely to be involved in the slow phase of 
folding. This is consistent with an earlier observation that the 
N-terminal signal peptide significantly slows folding of MBP 
[12]. It is also possible, though unlikely, that while the N- 
terminal residues are disordered in the protein crystal struc- 
ture, the situation may be different in solution. Alternatively 
the N-terminus may be ordered in cmMBP but not in 
pmMBP. 
The changes in physicochemical properties of a protein due 
to the presence of the extra unprocessed methionine at the N- 
terminus have recently been reported for two small recombi- 
nant proteins expressed hcterologously in E. coli, goat ~-lac- 
talbumin [13] and bovine c~-lactalbumin [14]. Table 3 corn- 
pares the large protein MBP with these two small proteins 
and it is evident that destabilization of the native structure 
is a common theme. The additional substitution of lle in 
pmMBP by Thr in cmMBP occurred because this mutation 
is already present in the pMALc2 plasmid (sequence obtained 
from the web-site URL http://www.neb.com) and has not 
occurred during the cloning process. The observed MW of 
cmMBP from ESI-MS (Fig. 3) agrees well with that calculated 
using the mature pmMBP sequence [15] corrected for both the 
Ile to Thr mutation and the additional N-terminal methionine 
residue. Analyses of the CNBr fragments from both pm- and 
cmMBP by MS (Table 2) show that there are no other differ- 
enccs in sequence between the two proteins. 
Peptide deformylase from E. coli is highly specific towards 
formyl group removal. The enzyme is active towards diverse 
peptide sequences bearing the fMet residue [16]. On the other 
hand, the action of methionyl aminopeptidase d pends on the 
size of the side chain of the residue adjacent o terminal me- 
thionine and methionyl removal is negligible when the side 
chain length of the adjacent residue exceeds 4 ~, [17]. The 
presence of an extra methionine and not formyl methionine 
residue at the N-terminus of purified cmMBP indicates that 
deformylation has indeed occurred but not demethionylation. 
In the case of cmMBP, the second residue is lysine, whose side 
chain length is 6.4 A and thus the presence of uncleaved 
methionine in cmMBP may be accounted for. 
The commercially available pMALc2 vector has been 
widely used for high level overexpression of proteins in E. 
coli cytoplasm as MBP fusions [18]. Our results indicate 
that cmMBP is destabilized at room temperature. This factor 
should be considered, in addition to in vivo expression levels, 
in choosing whether pmMBP or cmMBP be used as a fusion 
partner. It is widely accepted that buried residues are impor- 
Table 3 
Effect of extra N-terminal methionine retained on overexpression in E. coli 
Protein N,~ Mobility in native gel Stability Kinetics 
Folding Unfolding 
N-terminus first 4 residues 
MBP 370 No change Decreased 
Goat c~-LA 123 Greater Decreased 
Bovine c~-LA 124 N.R. Decreased 
Slower No change Disordered 
No change Faster Ordered 
N.R. N.R. Ordered 
N.R.: not reported. 
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tant determinants of protein stability [19]. However, the 
present work clearly shows that residues that are apparently 
in disordered regions of a protein may also affect folding 
kinetics and stability. A more complete explanatibn of this 
surprising observation must await structure determination of 
cmMBP. 
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